Phosphatidylinositol 3-kinase ? is required for the development of experimental cerebral malaria

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lacerda Queiroz, Norinne ^a   Brant, Fatima ^a   Rodrigues, David Henrique ^a   Vago, Juliana Priscila ^a   Rachid, Milene Alvarenga ^a   Sousa, Lirlândia Pires ^a   Teixeira, Mauro Martins ^a   Teixeira, Antonio Lucio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5 (6 QUINOXALINYLMETHYLENE) 2,4 THIAZOLIDINEDIONE; GRANZYME B; HERMES ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CG PROTEIN, MOUSE; QUINOXALINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN MALARIA; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; FEMALE; LUNG DISEASE; MICROGLIA; MORTALITY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PARASITEMIA; PATHOGENESIS; PLASMODIUM BERGHEI INFECTION; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CEREBRAL MALARIA; DISEASE MODEL; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENETICS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; PARASITOLOGY; PATHOLOGY; PLASMODIUM BERGHEI; SURVIVAL ANALYSIS;

MUS; PLASMODIUM BERGHEI;

ANIMALS; BRAIN; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; HUMANS; LUNG; MALARIA, CEREBRAL; MICE; PLASMODIUM BERGHEI; QUINOXALINES; SURVIVAL ANALYSIS; THIAZOLIDINEDIONES;

EID: 84925047363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119633     Document Type: Article

References (32)

1. Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol. 2006; 36(5):569-82. PMID: 16678181
2. Grau GE, Craig AG. Cerebral malaria pathogenesis: revisiting parasite and host contributions. Future Microbiol. 2012; 7(2):291-302. doi: 10.2217/fmb.11.155 PMID: 22324996
3. de Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002; 4(3):291-300. PMID: 11909739
4. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010; 137(5):755-72. doi: 10.1017/S0031182009991715 PMID: 20028608
5. Hearn J, Rayment N, Landon DN, Katz DR, de Souza JB. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun. 2000; 68(9):5364-76. PMID: 10948166
6. Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002; 169(11):6369-75. PMID: 12444144
7. Renia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, et al. Pathogenic T cells in cerebral malaria. Int J Parasitol. 2006; 36(5):547-54. PMID: 16600241
8. Claser C, Malleret B, Gun SY, Wong AY, Chang ZW, Teo P, et al. CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One. 2011; 6(4):e18720. doi: 10.1371/journal.pone.0018720 PMID: 21494565
9. Haque A, Best SE, Unosson K, Amante FH, de Labastida F, Anstey NM, et al. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol. 2011; 186(11):6148-56. doi: 10.4049/jimmunol.1003955 PMID: 21525386
10. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, et al. Perforin-dependent braininfiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol. 2003; 170(4):2221-8. PMID: 12574396
11. Van den Steen PE, Deroost K, Deckers J, Van Herck E, Struyf S, Opdenakker G. Pathogenesis of malaria-associated acute respiratory distress syndrome. Trends Parasitol. 2013; 29(7):346-58. doi:s 1016/j.pt.2013.04.006 PMID: 23742967
12. Rameh LE, Cantley LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem. 1999; 274(13):8347-50. PMID: 10085060
13. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med. 2005; 11(9):936-43. PMID: 16127437
14. Martin AL, Schwartz MD, Jameson SC, Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidylinositol 3-kinase. J Immunol. 2008; 180(4):2081-8. PMID: 18250413
15. Castor MG, Rezende BM, Bernardes PT, Vieira AT, Vieira EL, Arantes RM, et al. PI3Kgamma controls leukocyte recruitment, tissue injury, and lethality in a model of graft-versus-host disease in mice. J Leukoc Biol. 2011; 89(6):955-64. doi: 10.1189/jlb.0810464 PMID: 21402770
16. Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med. 2005; 11(9):933-5. PMID: 16127435
17. Azzi J, Moore RF, Elyaman W, Mounayar M, El Haddad N, Yang S, et al. The novel therapeutic effect of phosphoinositide 3-kinase-gamma inhibitor AS605240 in autoimmune diabetes. Diabetes. 2012; 61(6):1509-18. doi: 10.2337/db11-0134 PMID: 22403300
18. Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P, Lambert PH. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol. 1986; 137(7):2348-54. PMID: 3093572
19. Fauconnier M, Bourigault ML, Meme S, Szeremeta F, Palomo J, Danneels A, et al. Protein kinase Ctheta is required for development of experimental cerebral malaria. Am J Pathol. 2011; 178(1):212-21. doi: 10.1016/j.ajpath.2010.11.008 PMID: 21224058
20. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, Sousa LP, et al. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol. 2012; 180(1):246-55. doi: 10.1016/j.ajpath.2011.09.038 PMID: 22079430
21. Deb C, Howe CL. NKG2D contributes to efficient clearance of picornavirus from the acutely infected murine brain. J Neurovirol. 2008; 14(3):261-6. doi: 10.1080/13550280802105002 PMID: 18569460
22. LaFrance-Corey RG, Howe CL. Isolation of brain-infiltrating leukocytes. J Vis Exp. 2011;(52).
23. Senaldi G, Vesin C, Chang R, Grau GE, Piguet PF. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun. 1994; 62(4):1144-9. PMID: 8132319
24. Chang WL, Jones SP, Lefer DJ, Welbourne T, Sun G, Yin L, et al. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect Immun. 2001; 69(12):7341-8. PMID: 11705906
25. Rodrigues DH, Vilela MC, Barcelos LS, Pinho V, Teixeira MM, Teixeira AL. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2010; 222(1-2):90-4. doi: 10.1016/j.jneuroim.2010.02.018 PMID: 20350768
26. Li H, Park D, Abdul-Muneer PM, Xu B, Wang H, Xing B, et al. PI3Kgamma inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice. Neuroscience. 2013; 253:89-99. doi: 10.1016/j.neuroscience.2013.08.051 PMID: 24012746
27. Jin R, Song Z, Yu S, Piazza A, Nanda A, Penninger JM, et al. Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke. Stroke. 2011; 42(7): 2033-44. doi: 10.1161/STROKEAHA.110.601369 PMID: 21546487
28. Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, et al. Brain microvessel crosspresentation is a hallmark of experimental cerebral malaria. EMBO Mol Med. 2013; 5(7):916-31. doi: 10.1002/emmm.201202273 PMID: 23681698
29. Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, Wittner M, et al. Endothelin in a murine model of cerebral malaria. Exp Biol Med (Maywood). 2006; 231(6):1176-81. PMID: 16741072
30. Desruisseaux MS, Gulinello M, Smith DN, Lee SC, Tsuji M, Weiss LM, et al. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis. 2008; 197(11):1621-7. doi: 10.1086/587908 PMID: 18419550
31. Russo RC, Garcia CC, Barcelos LS, Rachid MA, Guabiraba R, Roffe E, et al. Phosphoinositide 3-kinase gamma plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. J Leukoc Biol. 2011; 89(2):269-82. doi: 10.1189/jlb.0610346 PMID: 21048214
32. Lacerda-Queiroz N, Rachid MA, Teixeira MM, Teixeira AL. The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria. Int J Parasitol. 2013; 43(1):11-5. doi: 10.1016/j.ijpara.2012.11.008 PMID: 23260771